Inventor · disambiguated record
Ralph Laufer
Also filed as: CORTESE RICCARDO · LAUFER RALPH
11 granted patents·10 pending applications·17 citations·filing 1997–2024
84Inventor score
Files withANGELETTI P IST RICHERCHE BIO6Prilenia Neurotherapeutics Ltd5AUSPEX PHARMACEUTICALS INC3CEPHALON INC2IRBM SCIENCE PARK S P A2
Top patents by PatentIndex Score
21 records- 0184US11406625B2Method of treating amyotrophic lateral sclerosis with pridopidinePrilenia Neurotherapeutics Ltd·Filed 2020·Granted Aug 9, 2022·2 cites·15 claims
- 0283US12102627B2Use of pridopidine for treating rett syndromePrilenia Neurotherapeutics Ltd·Filed 2020·Granted Oct 1, 2024·1 cites·25 claims
- 0374US11738012B2Treatment of neurodegenerative eye disease using pridopidinePrilenia Neurotherapeutics Ltd·Filed 2017·Granted Aug 29, 2023·1 cites·42 claims
- 0471US2024398778A1Use of pridopidine for treating rett syndromePrilenia Neurotherapeutics Ltd·Filed 2024·Application pending·0 cites
- 0569US9371295B2Compounds for use in the treatment of disorders that are ameliorated by inhibition of HDACIRBM—SCIENCE PARK S P A·Filed 2013·Granted Jun 21, 2016·4 cites·10 claims
- 0659US2019308934A1Prodrugs of ChlorokynureninesCEPHALON INC·Filed 2019·Application pending·0 cites
- 0753US9884819B2Tetrahydrocarbazole inhibitors of SIRT1 receptorsAUSPEX PHARMACEUTICALS INC·Filed 2017·Granted Feb 6, 2018·0 cites·14 claims
- 0853US2022062255A1Treatment of neurodegenerative eye disease using pridopidinePrilenia Neurotherapeutics Ltd·Filed 2021·Application pending·0 cites
- 0951US2018327351A1Prodrugs of chlorokynureninesCEPHALON INC·Filed 2016·Application pending·0 cites
- 1049US2018127366A1Tetrahydrocarbazole Inhibitors Of SIRT1 ReceptorsAUSPEX PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1148US6960558B2Method of screening for anti-obesity agents using ciliary neutrophic factor receptorANGELETTI P IST RICHERCHE BIO·Filed 2003·Granted Nov 1, 2005·0 cites·4 claims
- 1246US2021355506A1Compositions and methods for treating gm1 gangliosidosis and other disordersLYSOGENE·Filed 2021·Application pending·0 cites
- 1346US2008145886A1Assay for Cytochrome P450 Isoforms 3A4 and 3A5ANGELETTI P IST RICHERCHE BIO·Filed 2005·Application pending·0 cites
- 1443US2018305298A1Deuterated chlorokynurenines for the treatment of neuropsychiatric disordersAUSPEX PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 1542US7629140B2Assay for cytochrome P450 isoform 2C9ANGELETTI P IST RICHERCHE BIO·Filed 2005·Granted Dec 8, 2009·0 cites·8 claims
- 1640US6565869B1Use of CNTF (ciliary neurotrophic factor) receptor activators for the treatment of obesityANGELETTI P IST RICHERCHE BIO·Filed 1997·Granted May 20, 2003·4 cites·22 claims
- 1740US2018289637A1Substituted cyclohexanonesCLEXIO BIOSCIENCES LTD·Filed 2018·Application pending·0 cites
- 1838US2007264674A1Cytochrome P450 Induction AssayPAONESSA GIACOMO·Filed 2005·Application pending·0 cites
- 1936US9365541B2Compounds for use in the treatment of parasitic diseasesIRBM—SCIENCE PARK S P A·Filed 2013·Granted Jun 14, 2016·0 cites·9 claims
- 2036US6756357B1Variants of human ciliary neurotrophic factor (hCNTF)ANGELETTI P IST RICHERCHE BIO·Filed 1997·Granted Jun 29, 2004·3 cites·5 claims
- 2128US6660467B1Variant of ciliary neurotrophic factor and DNA encoding the variantANGELETTI P IST RICHERCHE BIO·Filed 1998·Granted Dec 9, 2003·2 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Ralph Laufer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →